A Trial of Metformin in Individuals With Fragile X Syndrome (Met)

Clinical trial NCT03862950 · COMPLETED

Trial details

NCT number: NCT03862950
Sponsor: University of Alberta
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Fragile X Syndrome Fragile X Mental Retardation Syndrome Mental Retardation, X-Linked Genetic Diseases, X-Linked Trinucleotide Repeat Expansion Fra(X) Syndrome Intellectual Disability FXS Neurobehavioral Manifestations Sex Chromosome Disorders

Start date: 2019-05-24
Primary completion: 2025-12-16
Enrollment: 125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.